Growth Metrics

AVITA Medical (AVHHL) Other financing activities (2021)

AVITA Medical posted quarterly Other financing activities of $5.1 million for Q3 2021, little changed on a QoQ basis from $5.1 million in Q1 2021.

AVITA Medical (AVHHL) has 1 years of Other financing activities data on file, last reported at $5.1 million in Q3 2021.

  • For the quarter ending Q3 2021, Other financing activities changed N/A year-over-year to $5.1 million; the trailing twelve-month figure through Sep 2021 stood at $10.2 million (changed N/A YoY), and the FY2021 full-year result was $5.1 million, up 0.63% from the prior year.
  • Other financing activities for Q3 2021 stood at $5.1 million, roughly flat from $5.1 million in the prior quarter.
  • Across five years, Other financing activities topped out at $5.1 million in Q1 2021 and bottomed at $5.1 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 AVITA Medical - - 14.31 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2021 5.11 Mn
Sep 30, 2021 5.11 Mn
Mar 31, 2021 5.11 Mn
Mar 31, 2021 5.11 Mn